First Time Loading...

Arkema SA
PAR:AKE

Watchlist Manager
Arkema SA Logo
Arkema SA
PAR:AKE
Watchlist
Price: 97.55 EUR 1.51% Market Closed
Updated: May 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

15.1B
+4%
Assets
Growth Rates:
1 Year
+9%
3 Years
+36%
5 Years
+43%
7 Years
+64%
10 Years
+158%
7.4B
+0.9%
Liabilities
Growth Rates:
1 Year
+12%
3 Years
+29%
5 Years
+37%
7 Years
+52%
10 Years
+112%
7.7B
+7%
Equity
Growth Rates:
1 Year
+6%
3 Years
+42%
5 Years
+49%
7 Years
+78%
10 Years
+225%

Balance Sheet Decomposition
Arkema SA

15.1B
Assets
7.4B
Liabilities
15.1B
Assets
7.4B
Liabilities
Current Assets 5.4B
Cash & Short-Term Investments 2.3B
Receivables 1.8B
Other Current Assets 1.3B
Non-Current Assets 9.7B
Long-Term Investments 65m
PP&E 3.7B
Intangibles 5.5B
Other Non-Current Assets 408m
Current Liabilities 2.9B
Accounts Payable 1.1B
Other Current Liabilities 1.8B
Non-Current Liabilities 4.5B
Long-Term Debt 3B
Other Non-Current Liabilities 1.5B

Balance Sheet
Arkema SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 149
711
623
1 438
1 441
1 407
1 587
2 285
1 592
2 045
Cash
89
148
222
755
633
1 206
1 003
1 451
664
667
Cash Equivalents
1 060
563
401
683
808
201
584
834
928
1 378
Short-Term Investments
2
15
10
0
0
0
0
0
0
0
Total Receivables
1 003
1 274
1 411
1 366
1 500
1 501
1 364
1 704
1 692
1 573
Accounts Receivables
839
1 051
1 150
1 115
1 247
1 204
1 131
1 432
1 360
1 261
Other Receivables
164
223
261
251
253
297
233
272
332
312
Inventory
977
1 129
1 111
1 145
1 136
1 014
881
1 283
1 399
1 208
Other Current Assets
0
0
0
17
7
95
231
113
79
32
Total Current Assets
3 131
3 129
3 155
3 966
4 084
4 017
4 063
5 385
4 762
4 858
PP&E Net
2 272
2 727
2 652
2 464
2 627
3 026
2 828
3 031
3 429
3 730
PP&E Gross
2 272
2 727
2 652
2 464
2 627
3 026
2 828
3 031
3 429
3 730
Accumulated Depreciation
4 901
6 677
6 884
6 055
6 377
6 792
6 650
7 422
7 866
8 122
Intangible Assets
347
1 090
1 074
1 181
1 259
1 475
1 433
1 517
2 178
2 416
Goodwill
747
1 320
1 703
1 525
1 618
1 917
1 933
1 925
2 655
3 040
Note Receivable
171
180
200
203
211
206
173
156
192
188
Long-Term Investments
70
82
95
87
100
119
122
132
128
126
Other Long-Term Assets
76
193
171
150
212
217
159
155
167
159
Other Assets
747
1 320
1 703
1 525
1 618
1 917
1 933
1 925
2 655
3 040
Total Assets
6 814
N/A
8 721
+28%
9 050
+4%
9 576
+6%
10 111
+6%
10 977
+9%
10 711
-2%
12 301
+15%
13 511
+10%
14 517
+7%
Liabilities
Accounts Payable
704
884
932
965
1 037
905
987
1 274
1 149
1 036
Accrued Liabilities
168
225
247
232
235
234
210
275
280
261
Short-Term Debt
0
0
0
0
0
0
0
0
442
389
Current Portion of Long-Term Debt
107
217
728
244
201
661
134
82
256
152
Other Current Liabilities
152
242
248
237
193
226
249
362
283
241
Total Current Liabilities
1 131
1 568
2 155
1 678
1 666
2 026
1 580
1 993
2 410
2 079
Long-Term Debt
1 196
1 873
1 377
2 250
2 246
2 377
2 663
2 680
2 560
3 734
Deferred Income Tax
57
307
285
271
268
334
320
342
362
436
Minority Interest
44
49
45
41
49
51
48
47
39
252
Other Liabilities
857
1 024
984
903
903
916
913
936
840
813
Total Liabilities
3 285
N/A
4 821
+47%
4 846
+1%
5 143
+6%
5 132
0%
5 704
+11%
5 524
-3%
5 998
+9%
6 211
+4%
7 314
+18%
Equity
Common Stock
728
745
757
759
766
766
767
767
750
750
Retained Earnings
844
1 003
1 250
1 670
2 147
2 380
2 486
3 626
4 451
4 537
Additional Paid In Capital
1 093
1 172
1 211
1 216
1 263
1 266
1 272
1 272
1 067
1 067
Treasury Stock
3
3
4
2
28
11
6
305
20
21
Other Equity
867
983
990
790
831
872
668
943
1 052
870
Total Equity
3 529
N/A
3 900
+11%
4 204
+8%
4 433
+5%
4 979
+12%
5 273
+6%
5 187
-2%
6 303
+22%
7 300
+16%
7 203
-1%
Total Liabilities & Equity
6 814
N/A
8 721
+28%
9 050
+4%
9 576
+6%
10 111
+6%
10 977
+9%
10 711
-2%
12 301
+15%
13 511
+10%
14 517
+7%
Shares Outstanding
Common Shares Outstanding
73
74
76
76
76
76
77
74
75
75

See Also

Summary
AKE intrinsic value, competitors valuation, and company profile.
DCF Valuation
AKE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AKE stock valuation using valuation multiples.
Wall Street Estimates
AKE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AKE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.